LexDanaLexDanabeta
Inventor

Liyuan YIN

Inventor
US

Overview

2→
Patents
2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments25%
PatentTitleYear
12,121,510Compounds and methods to sensitize cancer cells to cisplatin202411,878,000Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024Patents assigned to CEDARS SINAI MEDICAL CENTER (2)· patent assignee history
2024Patents assigned to DA ZEN THERANOSTICS INC (2)· patent assignee history
2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CEDARS SINAI MEDICAL CENTER22024
DA ZEN THERANOSTICS INC22024
Locations
LocationPatentsSpan
US22024